An error has occurred while submitting. Please try again later...
Your form was submitted successfully
Convenient. Curated. Connected. Training for the use of 3M™ Prevena™ Therapy in vascular surgery.
In a prospective, single-center, randomized controlled trial with patients undergoing vascular groin surgery, Prevena Therapy aided in:
Calculations are derived based on relative patient group incidence rate reported in this study.
*Statistically significant (p<0.05).
1. Kwon J, et al. A Randomized Clinical Trial Evaluating Negative Pressure Therapy to Decrease Vascular Groin Incision Complications. Journal of Vascular Surgery. 2018;68(6):1744-1752.
Resources to help you implement PRM with Prevena Therapy in your practice to help advance the standard of care.
Find detailed information about the use of Prevena Therapy in vascular surgery, including outcomes and cost-effectiveness.
Download the summary of findings for the use of Prevena Therapy for patients at high risk for groin wound complications.
View an illustrative guide to aid in risk stratification for vascular surgery.
A guide to supporting the use of Prevena Therapy in a variety of specialties.
Learn more about the use of Prevena Therapy in vascular surgery or request a product demonstration.
3M™ Prevena™ 125 and 3M™ Prevena™ Plus 125 Therapy Units manage the environment of closed surgical incisions and remove fluid away from the surgical incision via the application of -125mmHg continuous negative pressure. When used with legally marketed compatible dressings, Prevena 125 and Prevena Plus 125 Therapy Units are intended to aid in reducing the incidence of seroma and, in patients at risk for post-operative infections, aid in reducing the incidence of superficial surgical site infection in Class I and II wounds.
The effectiveness of Prevena Therapy in reducing the incidence of SSIs and seroma in all surgical procedures and populations has not been demonstrated. See full indications for use and limitations at myKCI.com.
NOTE: Applicable therapy units include Prevena™ 125 and Prevena™ Plus 125 Therapy Unit 7 Day.
The indication statement does not apply to the Prevena Plus 125 Therapy Unit (14-day) that comes with the 3M™ Prevena Restor™ System Kits (see Prevena Restor indications for use).
The 3M™ Prevena Restor™ Incision Management System is intended to manage the environment of surgical incisions that continue to drain following sutured or stapled closure by maintaining a closed environment and removing exudate via the application of negative pressure wound therapy.
NOTE: Specific indications, limitations, contraindications, warnings, precautions and safety information exist for these products and therapies. Please consult a clinician and product instructions for use prior to application. Rx only.